What's Hot and What's Not in Oncology
The take-home from the American Society of Clinical Oncology.
Most Post-Marketing Studies Deliver ''Duh'' Data
But no news is good news for a drug?s safety profile, a new study says
Amgen Lashes Out at Feds over Anemia Drug Coverage
Biotech takes issue with move to limit reimbursement.
